INTERNATIONAL PATENT: HANGZHOU JIAYIN BIOTECH LTD., EXEGENESIS BIO CO., EXEGENESIS BIO SINGAPORE PTE. LTD. FILES APPLICATION FOR "NOVEL LIVER DETARGETED AAV VARIANTS AND USES THEREOF"

GENEVA, Nov. 17 -- HANGZHOU JIAYIN BIOTECH LTD. (Room 401 Building 11, Hexiang Science and Technology Center, Qiantang DistrictHangzhou, Zhejiang 310018), EXEGENESIS BIO CO. (727 Norristown Road, Suite 160, Building 3, Spring House Innovation ParkLower Gwynedd, Pennsylvania 19002), EXEGENESIS BIO SINGAPORE PTE. LTD. (6 Raffles Quay, #14-06Singapore 048580) filed a patent application (PCT/CN2025/094088) for "NOVEL LIVER DETARGETED AAV VARIANTS AND USES THEREOF" on May 09, 2025. With publication no. WO/2025/232917, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Prop...